bf/NASDAQ:MIRO_icon.jpeg

NASDAQ:MIRO

Miromatrix Medical Inc.

  • Stock

USD

Last Close

3.37

12/12 21:00

Market Cap

92.95M

Beta: -

Volume Today

631.56K

Avg: 57.52K

PE Ratio

−3.41

PFCF: −3.79

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
400.05K
-
800.10K
100%
average payables
216.57K
-
1.11M
413.69%
1.84M
65.38%
average receivables
321.50K
-
694.99K
116.17%
1.16M
66.41%
book value per share
-3.95
-
-4.83
22.12%
4.71
197.61%
1.26
73.27%
capex per share
-0.01
-
-0.01
20.37%
-0.29
2,428.03%
-0.05
82.59%
capex to depreciation
-0.29
-
-0.72
145.23%
-20.15
2,687.00%
-0.96
95.24%
capex to operating cash flow
0.01
-
0.02
25.74%
0.23
1,390.83%
0.04
82.56%
capex to revenue
-0.41
-
-2.65
552.28%
-102.31
3,765.25%
-1.12
98.91%
cash per share
0.31
-
0.42
35.58%
4.60
993.63%
1.22
73.56%
days of inventory on hand
584.07
-
584.07
0%
days payables outstanding
442.36
-
95.02
78.52%
1.53K
1,509.45%
1.16K
24.34%
days sales outstanding
770.60
-
903.69
17.27%
14.07K
1,457.12%
397.44
97.18%
debt to assets
0.15
-
1.40
851.24%
0.01
99.02%
0.10
649.54%
debt to equity
-0.03
-
-0.14
423.89%
0.02
110.67%
0.14
786.60%
dividend yield
earnings yield
-0.02
-
-0.05
181.48%
-0.28
413.15%
-0.48
74.38%
enterprise value
157.60M
-
163.98M
4.05%
1.88M
98.85%
60.32M
3,105.34%
enterprise value over ebitda
-17.25
-
-14.33
16.96%
-0.11
99.22%
-2.02
1,698.99%
ev to operating cash flow
-18.93
-
-20.40
7.77%
-0.13
99.38%
-2.26
1,679.01%
ev to sales
630.39
-
3.52K
459.06%
56.91
98.39%
63.26
11.16%
free cash flow per share
-0.80
-
-0.77
3.98%
-1.58
105.17%
-1.34
15.50%
free cash flow yield
-0.05
-
-0.05
3.98%
-0.34
566.68%
-0.45
32.55%
graham net net
-4.34
-
-4.90
12.70%
4.12
184.22%
0.85
79.27%
graham number
5.11
-
9.46
85.40%
11.75
24.15%
6.41
45.49%
income quality
2.06
-
0.78
62.10%
1.01
29.47%
0.89
11.77%
intangibles to total assets
0
-
0
0
0
interest coverage
-185.84
-
-13.41
92.79%
-25.07
86.98%
-633.66
2,427.68%
interest debt per share
0.11
-
0.77
577.63%
0.13
82.89%
0.17
32.34%
inventory turnover
0.62
-
0.62
0%
invested capital
-0.03
-
-0.14
423.89%
0.02
110.67%
0.14
786.60%
market cap
159.71M
-
161.09M
0.86%
53.86M
66.56%
61.98M
15.06%
net current asset value
-45.31M
-
-51.60M
13.89%
48.53M
194.06%
18.66M
61.56%
net debt to ebitda
0.23
-
-0.25
209.50%
3.10
1,322.90%
0.06
98.21%
net income per share
-0.29
-
-0.82
181.48%
-1.30
57.92%
-1.45
11.17%
operating cash flow per share
-0.79
-
-0.76
4.27%
-1.29
69.57%
-1.29
0.17%
payables turnover
0.83
-
3.84
365.55%
0.24
93.79%
0.32
32.17%
receivables turnover
0.47
-
0.40
14.73%
0.03
93.58%
0.92
3,440.54%
research and ddevelopement to revenue
25.07
-
156.48
524.24%
325.12
107.78%
19.20
94.10%
return on tangible assets
-0.40
-
-1.66
318.52%
-0.25
85.20%
-0.86
251.67%
revenue per share
0.02
-
0.00
81.55%
0.00
34.60%
0.05
1,497.66%
roe
0.07
-
0.17
130.49%
-0.28
261.78%
-1.15
315.98%
roic
0.07
-
0.20
176.04%
-0.31
258.48%
-0.92
193.35%
sales general and administrative to revenue
9.74
-
45.33
365.21%
140.43
209.80%
9.15
93.49%
shareholders equity per share
-3.95
-
-4.83
22.12%
4.71
197.61%
1.26
73.27%
stock based compensation to revenue
3.67
-
13.86
277.22%
18.82
35.77%
1.21
93.58%
tangible asset value
-41.43M
-
-51.03M
23.17%
54.13M
206.06%
26.11M
51.77%
tangible book value per share
-3.95
-
-4.83
22.12%
4.71
197.61%
1.26
73.27%
working capital
2.25M
-
-3.47M
254.44%
50.77M
1,561.40%
22.36M
55.95%

All numbers in USD (except ratios and percentages)